Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Controlled clinical trial of four short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis.

× No keyword cloud information.

11 in total

Review 1. Comparative pharmacokinetics and pharmacodynamics of the rifamycin antibacterials.

Authors: W J Burman; K Gallicano; C Peloquin
Journal: Clin Pharmacokinet Date: 2001 Impact factor: 6.447

2. Tuberculosis, now and the future: short-term therapy, preventive therapy, and bacillus Calmette-Guérin.

Authors: P Q Edwards
Journal: Bull N Y Acad Med Date: 1977 Jul-Aug

3. Intermittent treatment regimens in pulmonary tuberculosis.

Authors: M Zierski
Journal: Lung Date: 1979 Impact factor: 2.584

4. Daily rifapentine for treatment of pulmonary tuberculosis. A randomized, dose-ranging trial.

Authors: Susan E Dorman; Radojka M Savic; Stefan Goldberg; Jason E Stout; Neil Schluger; Grace Muzanyi; John L Johnson; Payam Nahid; Emily J Hecker; Charles M Heilig; Lorna Bozeman; Pei-Jean I Feng; Ruth N Moro; William MacKenzie; Kelly E Dooley; Eric L Nuermberger; Andrew Vernon; Marc Weiner
Journal: Am J Respir Crit Care Med Date: 2015-02-01 Impact factor: 21.405

5. Paradoxical effect of isoniazid on the activity of rifampin-pyrazinamide combination in a mouse model of tuberculosis.

Authors: Deepak Almeida; Eric Nuermberger; Rokeya Tasneen; Ian Rosenthal; Sandeep Tyagi; Kathy Williams; Charles Peloquin; Jacques Grosset
Journal: Antimicrob Agents Chemother Date: 2009-07-20 Impact factor: 5.191

Review 6. Short-course therapy for tuberculosis.

Authors: M Aquinas
Journal: Drugs Date: 1982-08 Impact factor: 9.546

7. Pyrazinamide may improve fluoroquinolone-based treatment of multidrug-resistant tuberculosis.

Authors: Kwok-Chiu Chang; Chi-Chiu Leung; Wing-Wai Yew; Eric Chung-Ching Leung; Wai-Man Leung; Cheuk-Ming Tam; Ying Zhang
Journal: Antimicrob Agents Chemother Date: 2012-08-06 Impact factor: 5.191

8. Optimizing Bedaquiline for cardiotoxicity by structure based virtual screening, DFT analysis and molecular dynamic simulation studies to identify selective MDR-TB inhibitors.

Authors: Iqrar Ahmad; Harsha Jadhav; Yashodeep Shinde; Vilas Jagtap; Rukaiyya Girase; Harun Patel
Journal: In Silico Pharmacol Date: 2021-03-23

Review 9. Prevalence of inappropriate tuberculosis treatment regimens: a systematic review.

Authors: M W Langendam; M J van der Werf; E Huitric; D Manissero
Journal: Eur Respir J Date: 2011-10-17 Impact factor: 16.671

10. Investigation of Elimination Rate, Persistent Subpopulation Removal, and Relapse Rates of Mycobacterium tuberculosis by Using Combinations of First-Line Drugs in a Modified Cornell Mouse Model.

Authors: Yanmin Hu; Henry Pertinez; Fatima Ortega-Muro; Laura Alameda-Martin; Yingjun Liu; Alessandro Schipani; Geraint Davies; Anthony Coates
Journal: Antimicrob Agents Chemother Date: 2016-07-22 Impact factor: 5.191